JitendraGGandhiMD

Oncology • Houma, LA

Instructor, Clinical Education-Chattanooga, University of Tennessee Health Science Center College of Medicine

Join to view full profile

Dr. Gandhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gandhi's full profile

Already have an account?

Office
8166 Main St
Houma, LA 70360
Phone+1 985-857-8093

Fax+1 985-857-8902
Is this information wrong?

Education & Training

UMass Chan Medical SchoolResidency, Internal Medicine, 1982 - 1983
Seth G.S. Medical CollegeClass of 1976

Certifications & Licensure

TN State Medical License 1983 - 2026
GA State Medical License 1981 - 2024
LA State Medical License 2020 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer Start of enrollment: 2012 Sep 01
Completed
Phase 1, Phase 2
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01
Terminated
Phase 2
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Completed
Phase 2

Publications & Presentations

PubMed

13 citations
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
Richard Kim, E. Gabriela Chiorean, Manik Amin, Caio Rocha-Lima, Jitendra Gandhi, William P. Harris, Tao Song, David Portnoy> ;British Journal of Cancer. 2017 Jun 20
12 citations
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
Daniel P. Petrylak, Jitendra G. Gandhi, William R. Clark, Elisabeth I. Heath, Jianqing Lin, William Oh, David B. Agus, Bradley C. Carthon, Susan Moran, Ning Kong, Ashi...> ;Investigational New Drugs. 2015 Jan 4
17 citations
Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Ramaswamy Govindan, Daniel Morgensztern, Michael D. Kommor, Roy S. Herbst, Paul Schaefer, Jitendra Gandhi, Kaku Saito, C. Zergebel, Joan H. Schiller> ;Journal of Thoracic Oncology. 2011 Apr 1
2 citations
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer
David R. Spigel, John D. Hainsworth, Jitendra G. Gandhi, Victor G. Gian, James D. Peyton, Kimberly West-Osterfield, Bobby L. Clark, Elizabeth R. Vazquez, Suzanne F. Jo...> ;Journal of Thoracic Oncology. 2010 Jun 1
5 citations
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.
John D. Hainsworth, A. A. Meluch, Cassie M. Lane, David R. Spigel, Howard A. Burris, Jitendra G. Gandhi, Edward J. Crane, Michael A. Stipanov, F. Anthony Greco> ;Cancer Investigation. 2010 Feb 16
Vinflunine (VFL) as salvage chemotherapy in hormone-refractory prostate cancer (HRPC).
Meluch AA, Spigel DR, Burris HA, Greco FA, Gandhi J, Crane E, Markus TM, Hainsworth JD> ;J. Clin. Oncol.. 2008-05-20
57 citations
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer : A randomized ph...
John D. Hainsworth, David R. Spigel, C. Farley, Dianna Shipley, James D. Bearden, Jitendra G. Gandhi, Gerry Ann Houston, F. Anthony Greco> ;Cancer. 2007 Nov 1
14 citations
Paclitaxel/Carboplatin/Gemcitabine Versus Gemcitabine/Vinorelbine in Advanced Non-Small-Cell Lung Cancer: A Phase II/III Study of the Minnie Pearl Cancer Research Network
F. Anthony Greco, David R. Spigel, Michel E. Kuzur, Dianna Shipley, J. R. Gray, D. S. Thompson, Howard A. Burris, Denise A. Yardley, Asim Pati, Charles D. Webb, Jitend...> ;Clinical Lung Cancer. 2007 Sep 1
Topotecan-Single agent activity in a weekly intravenous (IV) schedule for first-line therapy in poor prognosis extensive stage small cell lung cancer (SCLC): A Minnie ...
Murphy PB, Hainsworth JD, Spigel DR, Gray JR, Liggett WH, Shipley DL, Switzer A, Gandhi JG, Dannaher CL, Greco FA> ;J. Clin. Oncol.. 2006-06-20
Paclitaxel, carboplatin, and gemcitabine (PCG) versus gemcitabine and vinorelbine (GV) in chemotherapy naïve patients (pts) with advanced non-small cell lung cancer (N...
Kuzur ME, Shipley DL, Spigel DR, Gray JR, Thompson DS, Hainsworth JD, Bradof JE, Webb CD, Gandhi JG, Beschorner A, Greco FA> ;J. Clin. Oncol.. 2005-06-01
Weekly docetaxel and estramustine monophosphate (EMP) in the treatment of patients with prostate cancer and persistent/recurrent PSA elevation following primary therap...
Mainwaring MG, Meluch AA, Greco FA, Gian VG, Kohler PC, Lahiry AK, Gandhi JG, Morrissey LH, Hainsworth JD> ;J. Clin. Oncol.. 2004-07-15
Weekly paclitaxel/estramustine phosphate plus carboplatin administered either weekly or every 4 weeks in the treatment of hormone refractory prostate cancer (HRPC): A ...
Meluch AA, Greco FA, Burris HA, Erland JB, Khan RA, Rodriguez GI, Gandhi JG, Hainsworth JD> ;J. Clin. Oncol.. 2004-07-15
1 citations
Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro
I.O. Szymanski, Richard A. Teno, Jitendra G. Gandhi, Peter E. Newburger> ;Vox Sanguinis. 1984 Nov 1
1 citations
A new low ionic strength test for assessment of pretransfusion compatibility. Studies in vitro and in vivo.
I.O. Szymanski, Jitendra G. Gandhi> ;American Journal of Clinical Pathology. 1983 Jul 1
Join now to see all

Hospital Affiliations

Terrebonne General Health SystemHouma, Louisiana
Tift Regional Medical CenterTifton, Georgia